Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC
Xu Zhou(Heidelberg University), Peter J. Bailey(Cambridge University Hospitals NHS Foundation Trust)
Cited by 57
Related Papers
Genomic basis for RNA alterations in cancer
|Nature|2020|424
Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers
|The American Journal of Human Genetics|2013|214